Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Baxter
Medtronic
McKesson
Express Scripts

Last Updated: February 28, 2020

DrugPatentWatch Database Preview

Litigation Details for BAUSCH HEALTH IRELAND LIMITED v. GLENMARK PHARMACEUTICALS LIMITED (D.N.J. 2019)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in BAUSCH HEALTH IRELAND LIMITED v. GLENMARK PHARMACEUTICALS LIMITED
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for BAUSCH HEALTH IRELAND LIMITED v. GLENMARK PHARMACEUTICALS LIMITED (D.N.J. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-06-28 1 Complaint Plaintiffs”) for infringement of U.S. Patent No. 8,809,307 (the “’307 Patent”) by Defendant Glenmark Pharmaceuticals…for infringement of the ’307 Patent. This action arises under the Patent Laws of the United States, 35… THE PATENT-IN-SUIT 16. On August 19, 2014, the ’307 Patent entitled “Pharmaceutical…’307 Patent is attached as Exhibit 1.) 17. The named inventors of the ’307 Patent are …the term of the ’307 Patent, including any extension(s) granted by the U.S. Patent and Trademark Office External link to document
2020-01-06 14 Dismissal, the term ‘“Patents-in-Suit” shall mean U.S. Patent No. 8,809,307 (“the °307 patent). 3. As used in…Glenmark stipulates that, until expiration of the Patents-in-Suit, Glenmark, including any of its Affiliates…, and assigns, is enjoined from infringing the Patents-in-Suit, on its own part or through any Affiliate…parties in connection with any infringement of the Patents-in-Suit by any such third parties, unless and to…2019 6 January 2020 3:19-cv-14502 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Johnson and Johnson
McKesson
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.